Tag:

Peter Marks

COVID-19: FDA Approves Updated Booster Shots Targeting New Variants COVID-19: FDA Approves Updated Booster Shots Targeting New Variants
Covid-19: FDA Approves Updated Booster Shots Targeting New Variants Health officials are one step closer to rolling out updated COVID-19 vaccines just in time for a rise in cases heading into the fall and winter months. The US Food and Drug Administration (FDA) approved new vaccines on Monday, Sept. 11, that are meant to better target currently circulating COVID-19 variants and provide better protection against hospitalization and death, the agency announced. Monday’s move affects vaccines manufactured by Moderna and Pfizer. The updated mRNA vaccines are each approved for people ages 12 and older and are authorized under emergency use for children ages 6 mo…
COVID-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA COVID-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA
Covid-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA The Food and Drug Administration has authorized the use of updated COVID-19 booster shots targeting the Omicron variant for younger children. The FDA announced the amended emergency use authorization of the bivalent Moderna and Pfizer booster vaccines on Wednesday, Oct. 12. Today, FDA amended the EUA of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups. https://t.co/C2Sx5Nkk0R pic.twitter.com/xsPfO2Mek3 — U.S. FDA (@US_FDA) October 12, 2022 The Moderna bivalent booster is autho…
COVID-19: FDA Expands Eligibility For Pfizer Booster To Children 5 Through 11 COVID-19: FDA Expands Eligibility For Pfizer Booster To Children 5 Through 11
Covid-19: FDA Expands Eligibility For Pfizer Booster To Children 5 Through 11 Federal health officials have granted emergency use authorization for a booster dose of the Pfizer-BioNTech COVID-19 vaccine in children. On Tuesday, May 17, the US Food and Drug Administration (FDA) announced that it is expanding eligibility for boosters to include children between the ages of 5 and 11 years old. That age group will be permitted to receive their booster shot five months after completing their initial COVID-19 vaccination series, officials said. FDA Commissioner Robert Califf said that while data shows COVID-19 is less severe in children, the vaccine and boosters can help …
COVID-19: FDA Authorizes Second Booster Shot For This Group Of Americans COVID-19: FDA Authorizes Second Booster Shot For This Group Of Americans
Covid-19: FDA Authorizes Second Booster Shot For This Group Of Americans Federal health officials authorized a second booster shot of both the Pfizer and Moderna COVID-19 vaccines for older Americans. On Tuesday, March 29, the Food and Drug Administration (FDA) announced that a second shot has been approved for Americans who are 50 and older once four months have passed since their initial booster. With the FDA's approval, the decision now falls on Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention (CDC), who is expected to sign off on the additional shot as soon as Tuesday afternoon. The second booster shot had already been …
COVID-19: Moderna Vaccine Gets Full Approval From FDA COVID-19: Moderna Vaccine Gets Full Approval From FDA
Covid-19: Moderna Vaccine Gets Full Approval From FDA Federal officials have granted full approval to Moderna’s COVID-19 vaccine following its authorization last year for emergency use. On Monday, Jan. 31, the Food and Drug Administration (FDA) announced that Moderna’s vaccine has been granted its full approval, joining the Pfizer shot which was authorized months ago. The move comes after tens of millions of doses of the Moderna vaccine have already been administered across the country. It also represents Moderna’s first FDA-approved product in the US. Officials said the FDA reviewed months of additional follow-up data submitted by Moderna to…
COVID-19: FDA Expands Pfizer Booster Eligibility Among Adolescents As Omicron Cases Skyrocket COVID-19: FDA Expands Pfizer Booster Eligibility Among Adolescents As Omicron Cases Skyrocket
Covid-19: FDA Expands Pfizer Booster Eligibility Among Adolescents As Omicron Cases Skyrocket As the Omicron COVID-19 variant rages across the country, federal health officials have expanded the eligibility for booster shots in younger Americans. The Food and Drug Administration (FDA) announced on Monday, Jan. 3 that it is expanding the eligibility for Pfizer and BioNTech booster shots to American between the ages of 12 and 15 years old as children return to school amid a surge of new COVID-19 infections. FDA vaccine chief Dr. Peter Marks said in a statement the agency made its decision because a booster “may help provide better protection against both the delt…
COVID-19: FDA Clears Moderna, Pfizer Boosters For All US Adults COVID-19: FDA Clears Moderna, Pfizer Boosters For All US Adults
Covid-19: FDA Clears Moderna, Pfizer Boosters For All US Adults Federal health officials have given the green light for all Americans to get COVID-19 booster shots for all adults. The Food and Drug Administration (FDA) authorized Moderna and Pfizer COVID-19 booster shots for all adults in the US 18 and older, paving the way for expanding the eligibility of boosters in advance of the holiday season. Previously, the FDA had only authorized booster shots for Americans 65 and older, and those who were at a high risk of contracting COVID-19 due to pre-existing conditions of their job. “Authorizing the use of a single booster dose of either the Moderna or Pf…
COVID-19: FDA Grants Full Approval For Pfizer Vaccines, With More Mandates Now Expected COVID-19: FDA Grants Full Approval For Pfizer Vaccines, With More Mandates Now Expected
Covid-19: FDA Grants Full Approval For Pfizer Vaccines, With More Mandates Now Expected The US Food and Drug Administration (FDA) has granted full approval to the Pfizer/BioNTech COVID-19 vaccine for anyone 16 and older. On Monday, Aug. 23, the FDA announced that the Pfizer vaccine has been granted full approval, which is expected to potentially open the door for more COVID-19 vaccine mandates. The Pentagon will mandate vaccines for its 1.4 million active-duty service members, following the FDA approval Monday. United Airlines recently said its employees will be required to show proof of vaccination within five weeks of regulatory approval.  Pfizer is the first COVID-1…
COVID-19: FDA Approves Changes To Moderna Vaccine COVID-19: FDA Approves Changes To Moderna Vaccine
Covid-19: FDA Approves Changes To Moderna Vaccine The Food and Drug Administration has approved changes to the Moderna COVID-19 vaccine. On Thursday, April 1, the FDA announced that it has ruled that Moderna can put 50 percent more vaccine dosages in each vial, moving from 10 doses each to 15, which will allow for a more expeditious rollout of the vaccine. The FDA is also allowing 11 doses to be extracted out of the current 10 dose vials. Additionally, the FDA authorized the Moderna vaccine to be kept at room temperature conditions once removed from the refrigerator for administration for 24 hours, an increase from the previous 12 hours. …